Featured Articles
Ipsen today announced that the European Commission (EC) has approved the use of Cabometyx® (cabozantinib) as a monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC) - Cabometyx.com
BASF has expanded the production capacity for its antioxidant Irganox® 1010 at its site on Jurong Island, Singapore, by integrating an additional production line into the existing production facilities - PlasticAdditives.BASF.com
GlobalFoundries, Inc. (GF) and Motorola Solutions announced a long-term agreement to safeguard the supply of innovative chip solutions for Motorola Solutions’ radios - [Nasdaq: GFS] - GF.com / MotorolaSolutions.com